Skip to content
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma®
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Menu
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma®
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma®
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Menu
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma®
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma®
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Menu
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma®
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma®
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
Menu
About
About EffRx
Business Strategy
Management Team
Therapeutic Areas
Osteoporosis
What is Osteoporosis
The Treatment Gap
The Adherence Gap
Adrenal Insufficiency
Congenital Adrenal Hyperplasia
Niemann-Pick Disease Type C
Rare Diseases
Rare Diseases in Europe
Orphan Medicines in Europe
Products & Pipeline
Binosto®
Alkindi®
Efmody®
Miglustat Dipharma®
Pipeline Overview
Business Development
In-Licensing
Swiss & European Market Entry
World Orphan Drug Alliance (WODA)
Affiliations
Newsroom
News
Press Releases
Contact
News
EffRx Featured as Member of WODA in Rare Revolution Magazine
July 6, 2022
EffRx Featured as Member of WODA in Rare Revolution Magazine
“World Orphan Drug Alliance (WODA): bringing therapies to underserved patients around the globe.”
Contact
Wolleraustrasse 41B, 8807 Freienbach, Switzerland
+41 44 503 78 60
info@effrx.com
SHARE THIS ARTICLE
